Effectiveness of luseogliflozin over conventional therapy on liver fibrosis, disease activity and metabolic attributes in patients with metabolic associated fatty liver disease and type ii diabetes mellitus: an open-label randomized controlled trial
Background Metabolic Associated Fatty Liver Disease (MAFLD) is a new term that describes a spectrum of liver disease with its causative metabolic factors comprising obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. To this day, there is no definitive treatment for this condition. T...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2023
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/62347/ http://eprints.usm.my/62347/1/Mohamad%20Syamil%20Mazri-E.pdf |